Previous close | 0.5006 |
Open | 0.4780 |
Bid | 0.4093 x N/A |
Ask | 0.5620 x N/A |
Day's range | 0.4780 - 0.4780 |
52-week range | 0.2819 - 1.4498 |
Volume | |
Avg. volume | 215 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
RICHMOND, Calif., May 09, 2024--SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FIRST QUARTER 2024 FINANCIAL RESULTS
RICHMOND, Calif., May 09, 2024--Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing
RICHMOND, Calif., May 02, 2024--Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast